Bigelow Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $772K | Sell |
6,009
-194
| -3% | -$22.7K | 0.28% | 88 |
|
|
2026
Q1 | $746K | Sell |
6,203
-511
| -8% | -$59K | 0.3% | 86 |
|
|
2025
Q4 | $707K | Sell |
6,714
-408
| -6% | -$38.3K | 0.28% | 90 |
|
|
2025
Q3 | $598K | Sell |
7,122
-518
| -7% | -$42.7K | 0.24% | 95 |
|
|
2025
Q2 | $605K | Sell |
7,640
-1,170
| -13% | -$93K | 0.27% | 95 |
|
|
2025
Q1 | $791K | Sell |
8,810
-3,670
| -29% | -$343K | 0.38% | 79 |
|
|
2024
Q4 | $1.24M | Sell |
12,480
-1,046
| -8% | -$108K | 0.58% | 48 |
|
|
2024
Q3 | $1.54M | Sell |
13,526
-528
| -4% | -$62.7K | 0.68% | 40 |
|
|
2024
Q2 | $1.74M | Sell |
14,054
-335
| -2% | -$43.2K | 0.83% | 30 |
|
|
2024
Q1 | $1.9M | Sell |
14,389
-1,012
| -7% | -$125K | 0.93% | 30 |
|
|
2023
Q4 | $1.68M | Sell |
15,401
-300
| -2% | -$31.1K | 0.91% | 29 |
|
|
2023
Q3 | $1.62M | Sell |
15,701
-53
| -0.3% | -$5.71K | 0.93% | 28 |
|
|
2023
Q2 | $1.82M | Buy |
15,754
+95
| +0.6% | +$10.8K | 0.99% | 24 |
|
|
2023
Q1 | $1.67M | Sell |
15,659
-527
| -3% | -$56.9K | 0.96% | 26 |
|
|
2022
Q4 | $1.8M | Sell |
16,186
-410
| -2% | -$41.9K | 1.04% | 23 |
|
|
2022
Q3 | $1.43M | Buy |
16,596
+465
| +3% | +$41.5K | 0.85% | 32 |
|
|
2022
Q2 | $1.47M | Buy |
16,131
+666
| +4% | +$59K | 0.81% | 36 |
|
|
2022
Q1 | $1.27M | Buy |
15,465
+231
| +2% | +$18.2K | 0.59% | 48 |
|
|
2021
Q4 | $1.17M | Buy |
15,234
+32
| +0.2% | +$2.55K | 0.53% | 51 |
|
|
2021
Q3 | $1.14M | Sell |
15,202
-776
| -5% | -$59K | 0.56% | 49 |
|
|
2021
Q2 | $1.24M | Sell |
15,978
-805
| -5% | -$59.9K | 0.6% | 43 |
|
|
2021
Q1 | $1.24M | Sell |
16,783
-71
| -0.4% | -$5.24K | 0.63% | 43 |
|
|
2020
Q4 | $1.32M | Sell |
16,854
-52
| -0.3% | -$3.98K | 0.7% | 38 |
|
|
2020
Q3 | $1.34M | Sell |
16,906
-131
| -0.8% | -$10.3K | 0.79% | 34 |
|
|
2020
Q2 | $1.26M | Buy |
17,037
+307
| +2% | +$23.1K | 0.82% | 33 |
|
|
2020
Q1 | $1.23M | Sell |
16,730
-207
| -1% | -$16.3K | 0.92% | 25 |
|
|
2019
Q4 | $1.47M | Sell |
16,937
-84
| -0.5% | -$6.9K | 0.86% | 30 |
|
|
2019
Q3 | $1.37M | Sell |
17,021
-121
| -0.7% | -$9.7K | 0.87% | 31 |
|
|
2019
Q2 | $1.37M | Sell |
17,142
-743
| -4% | -$56.9K | 0.92% | 26 |
|
|
2019
Q1 | $1.42M | Sell |
17,885
-20,193
| -53% | -$1.51M | 0.98% | 24 |
|
|
2018
Q4 | $2.78M | Buy |
+38,078
| New | +$2.69M | 2.07% | 9 |
|
Other funds holding MRK
Bigelow Investment Advisors's MRK Position: Q2 2026 in Review
Bigelow Investment Advisors reduced its Merck (MRK) stake by 3.1% in Q2 2026, selling an estimated $22.7K and leaving 6,009 shares worth $772K. The position accounts for 0.28% of the portfolio, ranked #88.
Bigelow Investment Advisors first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.78M in Q4 2018. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Bigelow Investment Advisors held 6,009 shares of Merck worth $772K as of Q2 2026.
- Bigelow Investment Advisors sold 194 Merck shares in Q2 2026, an estimated $22.7K.
- Merck made up 0.28% of Bigelow Investment Advisors's portfolio in Q2 2026, its #88 holding.
- Bigelow Investment Advisors first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Bigelow Investment Advisors's Merck position peaked at $2.78M in Q4 2018.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Bigelow Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.